BioSpace News Archive

Product expansion comes as UnitedHealthcare issues positive coverage decision on PGx testing, including Genomind’s service, for certain patients with major depressive disorder or anxiety

Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company.

The global blepharitis drugs market is expected to post a CAGR of over 5% during the period 2019-2023, according to the latest market research report by Technavio.

In a joint announcement today, the leaders of PATH and the Telemedicine and Telehealth Service Provider Summit (SPS) have agreed to have SPS formally incorporated into PATH

Qfix and Mevion Medical Systems are pleased to announce that a special version of the kVue™ One Proton couch top is now both validated and available on MEVION S250™ Series Proton Therapy Systems.

Veltex Corporation – OTC Markets symbol (VLXC) Veltex Corporation (“Veltex”) announces the appointment of Luba Andrus, RPh., M.J. to the Board of Directors.

TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, has today announced the introduction of chameleon, an industry-enabling sample-preparation system for cryo-electron microscopy (cryo-EM).

The Pediatric Academic Societies (PAS) is pleased to announce Francis S. Collins, MD, PhD, as the keynote speaker at the PAS 2020 Meeting, taking place April 29 through May 6 in Philadelphia.

Roche (SIX: RO, ROG; OTCQX: RHHBY) will launch its presence at the American Association for Clinical Chemistry (AACC) 2019 Clinical Lab Expo in Anaheim by showcasing how health networks are driving change in the lab and beyond.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), today confirmed that the first patient enrolled in a single blinded, phase 2 clinical trial in patients with epidermolysis bullosa (EB) has positively responded to RGN-137, the Company’s novel topically-administered drug candidate.